Table 2. Prevalence of Metabolic Disorders Among the PCOS Phenotypes (age ≥ 18).
| Parameter(No./valid value (%)) | HA+OD(N = 107) | PCO+HA(N = 303) | PCO+HA+OD(N = 1197) | PCO+OD(N = 535) | P value |
|---|---|---|---|---|---|
| Glucose metabolic disorders | |||||
| DM | 5/93(5.4%) | 13/286(4.5%) | 46/1136(4.0%) | 14/467(3.0%) | 0.590 |
| IFG | 9/93(9.7%) | 46/285(16.1%) | 160/1135(14.1%) | 52/466(11.2%) | 0.145 |
| IGT | 14/81(17.3%) | 55/268(20.5%) | 223/1084(20.6%) | 80/444(18.0%) | 0.636 |
| Pre-DM | 20/93(21.5%) | 78/286(27.3%) | 333/1136(29.3%) | 114/467(24.4%) | 0.122 |
| Obesity | 36/105(34.3%) | 111/297(37.4%) | 451/1182(38.2%) | 167/526(31.7%) | 0.078 |
| Central obesity | 29/85(34.1%) | 91/249(36.5%) | 416/1070(38.9%) | 163/475(34.3%) | 0.338 |
| IR | 35/91(38.5%) | 80/281(28.5%) | 386/1122(34.4%) | 138/458(30.1%) | 0.089 |
| Other metabolic disorders | |||||
| MS | 9/70(12.9%) | 32/227 (14.1%) | 176/997 (17.7%) | 53/411(12.9%) | 0.106 |
| Hyperlipidemia | 27/67(40.3%) | 107/213 (50.2%) | 454/950 (47.8%) | 175/391(44.8%) | 0.373 |
DM: diabetes mellitus, IFG: impaired fasting glucose, IGT: impaired glucose tolerance, IR: insulin resistance, MS: metabolic syndrome, pre-DM: pre-diabetes mellitus, including IFG and IGT. HA+OD is the phenotype which has androgen excess and ovulation dysfunction without polycystic ovary morphology,. PCO+HA+OD is the classic reproductive phenotype which has polycystic ovary morphology, androgen excess and ovulation dysfunction. PCO+HA is the ovulatory phenotype which has polycystic ovary morphology and androgen excess with ovulation. PCO+OD is the phenotype which has polycystic ovary morphology and ovulation dysfunction without androgen excess.